Sol-Gel Technologies (SLGL) Retained Earnings (2016 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Retained Earnings came in at -$240.7 million in Q1 2026, little changed year-on-year from -$241.8 million in Q1 2025, and down 1.57% on a QoQ basis from -$237.0 million in Q4 2025.

Sol-Gel Technologies (SLGL) Retained Earnings (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Retained Earnings data on file, last reported at -$240.7 million in Q1 2026.

  • On a quarterly basis, Retained Earnings changed 0.44% year-over-year to -$240.7 million in Q1 2026; TTM through Mar 2026 was -$240.7 million, a 0.44% change from a year earlier, with the FY2025 full-year figure at -$237.0 million, down 2.65% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$240.7 million, down from -$237.0 million in the prior quarter.
  • Over the last five years, Retained Earnings for SLGL reached as high as -$183.7 million in Q1 2022 and fell as low as -$240.7 million in Q1 2026.
  • Historically, Retained Earnings has averaged -$216.7 million across 5 years, with a median of -$224.7 million in 2024.
  • Across the five-year window, Retained Earnings rose 4.96% in 2022 and slipped 15.05% in 2023, its largest moves.
  • Year by year, Retained Earnings stood at -$193.1 million in 2022, then fell by 14.11% to -$220.3 million in 2023, then retreated by 4.8% to -$230.9 million in 2024, then dropped by 2.65% to -$237.0 million in 2025, then retreated by 1.57% to -$240.7 million in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were -$240.7 million in Q1 2026, -$237.0 million in Q4 2025, and -$234.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -527.87 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -27.89 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.91 Bn
4 NuCana 279.75 Bn 279.75 Bn - 115.82 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 11.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -622,000.00
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - -240.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -240.74 Mn
Dec 31, 2025 -237.01 Mn
Sep 30, 2025 -234.02 Mn
Jun 30, 2025 -228.08 Mn
Mar 31, 2025 -239.69 Mn
Dec 31, 2024 -230.88 Mn
Sep 30, 2024 -225.04 Mn
Jun 30, 2024 -224.67 Mn
Mar 31, 2024 -226.65 Mn
Dec 31, 2023 -220.30 Mn
Sep 30, 2023 -215.47 Mn
Jun 30, 2023 -209.76 Mn
Mar 31, 2023 -203.33 Mn
Dec 31, 2022 -193.07 Mn
Sep 30, 2022 -187.28 Mn
Jun 30, 2022 -183.87 Mn
Mar 31, 2022 -183.74 Mn
Dec 31, 2021 -178.14 Mn
Sep 30, 2021 -192.17 Mn
Jun 30, 2021 -193.46 Mn